Bamaquimast

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameBamaquimast
Drug Alias Namebamaquimastum巴马司特F-10126L-0042
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMediator release inhibitors
TargetsNot applicable
Therapy Area/IndicationsAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPierre Fabre Group
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPierre Fabre Group
Active IndicationsN/A
Inactive IndicationsAsthma

Other Information

ATC CodeN/A
Related LinksN/A